Home › Generalized Anxiety Disorder › Florida
Generalized Anxiety Disorder clinical trials in Florida
7 studies for Generalized Anxiety Disorder are looking for participants at sites in Florida.
Cities in Florida
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
- Sunshine Medical Research Studies Inc, Miami
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07807865Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
- Premier Clinical Research, Miami
- Global Medical Institutes, Miami
- Miami Dade Medical Research Institute, Miami
- and 3 more
RecruitingPhase 2
All ages · All sexes · Updated Sep 25, 2026 · NCT06480383Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- Miami Dade Medical Research Institute, Miami
- University of South Florida, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06701903RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
- Innovative Clinical Research, Inc., Lauderhill
- University of South Florida, Tampa
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Sep 24, 2026 · NCT07489651A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
- Sarkis Clinical Trials - Gainesville, Gainesville
- Clinical Neuroscience Solutions, LLC, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07759128A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
- Clinical Neuroscience Solutions Inc. (CNS) - Orlando, Orlando
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07767903Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
- Cns Healthcare - Jacksonville /ID# 268588, Jacksonville
- Accel Research Sites Network - St. Pete /ID# 267821, Largo
- K2 Medical Research, LLC /ID# 267841, Maitland
- and 3 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jun 17, 2026 · NCT06846320From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.